T-test analysis revealed that HOTAIRM1 (P < 0.04) and HOXA9 (P < 0.03) expression levels were significantly higher in the AML-nonM3 group compared to the AML-M3 group. This evidence concerns the gene HOTAIRM1 and acute myeloid leukemia.